Related Experiment Video
Updated: May 21, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 10, 2011
Pediatric Invasive Group A Streptococcus Infections with Central Nervous System Involvement: A Single Institution
Natalie Qin1, Justin Morris2, Kelsey Hart3
1Pediatrics Residency Program, Hasbro Children's Brown University Health, Providence, RI.
Insights
Pediatric invasive Group A Streptococcus (iGAS) CNS infections are rare but serious. This case series highlights three pediatric iGAS CNS infections in Massachusetts, emphasizing the need for prompt recognition and treatment.
Area of Science:
- Pediatrics
- Infectious Diseases
- Neurology
Background:
- Invasive Group A Streptococcus (iGAS) infections in children, particularly those affecting the central nervous system (CNS), are uncommon but associated with severe outcomes.
- An increase in pediatric iGAS infections, including CNS involvement, has been observed globally post-COVID-19 pandemic.
- Limited regional data exists for pediatric iGAS infections in New England.
Purpose of the Study:
- To describe a unique cluster of three pediatric invasive Group A Streptococcus (iGAS) central nervous system (CNS) infections.
- To highlight the clinical presentation, management, and outcomes of these severe pediatric infections.
- To raise awareness of iGAS as a potential cause of invasive bacterial infections in children, especially in light of rising incidence.
Main Methods:
- A case series describing three pediatric patients with iGAS CNS infections.
- Cases presented within a two-month period in early 2025.
- All cases were geographically clustered within Massachusetts.
Main Results:
- All three patients presented with meningitis and subdural collections on brain imaging.
- Treatment involved prolonged intravenous antibiotics (≥4 weeks), with one patient requiring surgery.
- All patients experienced significant morbidity, including seizures requiring long-term therapy, focal weakness, and developmental delay.
Conclusions:
- Pediatric intracranial iGAS infections are severe and potentially life-threatening.
- The similar presentation, timing, and geographic proximity of these three cases are noteworthy.
- Clinicians should consider GAS as a potential pathogen in pediatric patients with invasive bacterial infections, especially CNS involvement.
Abstract:
Pediatric invasive Group A Streptococcus (iGAS) infections are rare, affecting sterile sites including the central nervous system (CNS), and cause significant morbidity and mortality. An increased incidence of pediatric iGAS infections, including cases with CNS involvement, has been noted following the COVID-19 pandemic both domestically and internationally. Regional New England iGAS data specific to pediatric populations have been limited. This case series describes three pediatric cases of iGAS with CNS involvement which presented within the same two-month period in early 2025, all from within 20 miles in Massachusetts. All were initially admitted to the pediatric intensive care unit, patients had meningitis and subdural collections on brain imaging, and subsequently required at least four weeks of intravenous antibiotics. One underwent surgical intervention. All three had seizures requiring long-term anti-epileptic therapy, and each had residual symptoms, including seizures, focal weakness, and developmental delay. GAS infections with intracranial involvement are often severe and life-threatening. This series of three pediatric intracranial iGAS cases is particularly unique due to their similar presentations, timing, and geographic proximity. With recent literature indicating rising rates of iGAS infections globally and our regional experience, GAS should be considered a potential culprit for patients presenting with invasive bacterial infections.
Related Concept Videos
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Viral Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Encephalitis l: Introduction
Brain Abscess l: Introduction

